Elevated tumor and serum levels of the hypoxia-associated protein osteopontin are associated with prognosis for soft tissue sarcoma patients.
about
The clinical importance of assessing tumor hypoxia: relationship of tumor hypoxia to prognosis and therapeutic opportunitiesA pilot study on potential plasma hypoxia markers in the radiotherapy of non-small cell lung cancer. Osteopontin, carbonic anhydrase IX and vascular endothelial growth factor.Prognostic impact of mRNA levels of osteopontin splice variants in soft tissue sarcoma patients.Effects of osteopontin inhibition on radiosensitivity of MDA-MB-231 breast cancer cellsPre- and post-translational regulation of osteopontin in cancer.Clinical significance of serum biomarkers in pediatric solid mediastinal and abdominal tumors.Preoperative platelet-lymphocyte ratio is superior to neutrophil-lymphocyte ratio as a prognostic factor for soft-tissue sarcoma.Identification of therapeutic targets for glioblastoma by network analysis.Inflammatory stress and sarcomagenesis: a vicious interplay.Osteopontin: a potentially important therapeutic target in cancer.Molecular Predictors of Radiotherapy Response in Sarcoma.Osteopontin: its potential role in cancer of children and young adults.Tumor expression of survivin, p53, cyclin D1, osteopontin and fibronectin in predicting the response to neo-adjuvant chemotherapy in children with advanced malignant peripheral nerve sheath tumor.
P2860
Q27025579-E08D7802-4A36-48AB-AAB4-3639D6FD4556Q30317585-29BB37B2-644B-4C32-BF06-3840865DD675Q30318127-A54157AE-47E2-4A1A-B615-C3772066F9B5Q34173692-93A4D0D7-B2B7-4103-85B5-11AA900B2A71Q34939938-EC67845E-F58E-40E9-AD83-2769DFF5CBE8Q35719602-23E68E52-5BA2-4239-A467-E49F4584C97CQ35797850-B99B0C2C-D8C6-4A4C-8A41-C3DA9018708DQ36271573-E4D124F0-FB08-4F61-8EE8-5B6A3686BD5CQ37378867-6ECE8B78-E471-4DE1-BC8F-38D5516543F4Q37896087-B1450A14-F25B-4E0F-83A0-FCF1A51EE033Q38682324-24AF0E87-CECE-4BEA-9466-0ACEB6F48161Q39192350-0AC556F4-D402-4714-B5DF-D12CC5796808Q47733296-EBA2FF0C-3806-4599-854D-69FBDBB502DF
P2860
Elevated tumor and serum levels of the hypoxia-associated protein osteopontin are associated with prognosis for soft tissue sarcoma patients.
description
2010 nî lūn-bûn
@nan
2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Elevated tumor and serum level ...... soft tissue sarcoma patients.
@ast
Elevated tumor and serum level ...... soft tissue sarcoma patients.
@en
Elevated tumor and serum level ...... soft tissue sarcoma patients.
@nl
type
label
Elevated tumor and serum level ...... soft tissue sarcoma patients.
@ast
Elevated tumor and serum level ...... soft tissue sarcoma patients.
@en
Elevated tumor and serum level ...... soft tissue sarcoma patients.
@nl
prefLabel
Elevated tumor and serum level ...... soft tissue sarcoma patients.
@ast
Elevated tumor and serum level ...... soft tissue sarcoma patients.
@en
Elevated tumor and serum level ...... soft tissue sarcoma patients.
@nl
P2093
P2860
P356
P1433
P1476
Elevated tumor and serum level ...... r soft tissue sarcoma patients
@en
P2093
Antje Hahnel
Dirk Vordermark
Henri Wichmann
Matthias Bache
Matthias Kappler
Matthias Kotzsch
Peter Würl
Swetlana Rot
Thomas Greither
P2860
P2888
P356
10.1186/1471-2407-10-132
P407
P577
2010-04-08T00:00:00Z
P5875
P6179
1008677370